
When we talk about the vitamin K family, vitamin K2 often stands out — not only for its role in bone health and cardiovascular protection, but also because of the fascinating differences within its own family members.
Two key players are MK4 (Menaquinone-4) and MK7 (Menaquinone-7). On paper they sound similar, but in practice, they’re very different:
👉 VK4 (Menaquinone-4)
Effective dosage: 45 mg/day
Duration: short, needs multiple doses daily
Impact on serum K2: minimal
Source: synthetic only
Absorption: quick
👉 VK7 (Menaquinone-7)
Effective dosage: 45 μg/day (yes, micrograms, not milligrams!)
Duration: long, once a day is enough
Impact on serum K2: 7–8× increase
Source: natto (fermentation) or synthesis
Absorption: quick
🤖 While both are absorbable, VK7 offers a much longer half-life and stronger impact on serum levels, which is why it’s often the preferred choice for supplement formulations today.
I’m curious — in your market or product development experience, do you see more demand for VK4 or VK7?

What do MK4 and MK-7 mean when we use vitamin K2?
2025-08-29
Ergothioneine's Global Moment: Regulations Set, Supply Chain Expanding
2025-08-05
Betaine from Beets: Nature’s Exercise Mimic
2025-07-11
China Opens $3.3B Door: Allulose’s Strategic Approval & What It Means for Global Health Brands
2025-07-02© Copyright All Rights Reserved.Joy-natural.biotech Ltd.